Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay
Context: Polycystic ovary syndrome diagnosed by Rotterdam criteria, is the most common cause of anovulatory infertility. The criteria of polycystic ovarian morphology (PCOM) are subject to operator variability and technological advances. Serum anti-Müllerian hormone (AMH) level has been proposed as...
Main Authors: | Nalini Mahajan, Jasneet Kaur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Human Reproductive Sciences |
Subjects: | |
Online Access: | http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2019;volume=12;issue=2;spage=104;epage=113;aulast=Mahajan |
Similar Items
-
Evaluation of ultrasonographic and Anti-Müllerian Hormone (AMH) changes as predictors for ovarian reserve after laparoscopic ovarian drilling for women with polycystic ovarian syndrome
by: Emad M. Seyam, et al.
Published: (2014-12-01) -
Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01) -
Anti-Mullerian Hormone (AMH) as a Predictor of Ovarian Response to Clomiphene Citrate in Polycystic Ovarian Syndrome
by: Serajoom Munira, et al.
Published: (2021-09-01) -
Anti-Müllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure
by: Piotr Skałba, et al.
Published: (2011-06-01) -
The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer
by: Richard A. Anderson, et al.
Published: (2020-10-01)